MedPath

Study comparing skin marking with pen and Mehendi for Radiotherapy

Not Applicable
Conditions
Health Condition 1: C00-D49- Neoplasms
Registration Number
CTRI/2017/07/008970
Lead Sponsor
Dr Suparna Kanti pal
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.adult cancer patients scheduled to receive Radiotherapy for more than 4 weeks

2.who require skin marking of borders of the fields for radiotherapy purpose

3. Performance status ECOG:0-2

4. Able and Willing to provide Informed Consent

Exclusion Criteria

1.Allergic to Mehendi

2. Mehendi marking not visible in room light over the skin surface due to reasons like local pigmentation or scars.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
o of days one application of Mehendi Vs Pen marker is usefulTimepoint: No of days one application of Mehendi Vs Pen marker is useful
Secondary Outcome Measures
NameTimeMethod
Satisfaction of other Oncologists regarding the convenience and procedureTimepoint: At the end of the study;satisfaction of patientTimepoint: At the end of Radiotherapy;Satisfaction of Radiotherapy Technicians to the procedureTimepoint: At the end of the study;Time required for each application and the optimal timeTimepoint: End of application of markings
© Copyright 2025. All Rights Reserved by MedPath